Paragon Biosciences LLC
Venture studioChicago · Seed–Series A · 1 people tracked
Investment thesis
Paragon Biosciences operates as a company creator, combining best practices of established organizations with a portfolio approach to advanced science. It launches new companies built around cutting-edge scientific breakthroughs, supporting them with in-house capabilities across clinical development, regulatory affairs, manufacturing, and commercialization. Its focus centers on life sciences and biotechnology, aiming to translate emerging science into commercial-stage businesses.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's website
What they invest in
from 5 of 6 portfolio companiesBiotech ×5Medical Devices ×4Deep Tech ×2Digital Health ×1Healthtech ×1
HQs:United States×2
Investments · 6 tracked
founders shown can be your intro pathHarmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases.
BiotechHealthtechMedical DevicesNorthbrook, US
Jeffrey M. Dayno, M.D.(President and Chief Executive Officer)Patrick Morris(Secretary and Treasurer)Jeffrey Aronin(Director)Dr. Andreas Wicki(Director)Robert Repella(Director and Chief Executive Officer)Martin Edwards(Director)
CiRC Biosciences develops cellular reprogramming therapies that convert fibroblasts directly into specific neurons and cell types lost in degenerative eye and brain diseases.
BiotechDeep TechMedical Devices
Emalex Biosciences is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders, including ecopipam, an investigational dopamine D1 receptor antagonist for pediatric Tourette syndrome.
BiotechMedical Devices
Castle Creek Biosciences develops re-dosable gene therapies for genetic diseases, with a lead candidate (D-Fi) in registrational clinical trials for dystrophic epidermolysis bullosa.
BiotechDeep TechMedical DevicesExton, US
Matthew Gantz(President and Chief Executive Officer)David ChuMichael TownsleyChristopher J. LarsonRhea WilliamsJude Sullivan(Executive Officer)
Exits · 1
IPOs and acquisitions across the tracked portfolioHarmony BiosciencesNASDAQ: HRMY
Portfolio news
latest coverage across their companiesHarmony Biosciences · investing.com · Jul 17, 2026
Castle Creek Biosciences · globenewswire.com · Feb 25, 2025
Frequently asked questions
- What stage does Paragon Biosciences LLC invest at?
- Paragon Biosciences LLC invests at the Seed, Series A stages.
- What sectors does Paragon Biosciences LLC focus on?
- Paragon Biosciences LLC focuses on Biotech, Healthtech, Longevity.
- Where is Paragon Biosciences LLC located?
- Paragon Biosciences LLC is headquartered in Chicago, US.
Media · Podcasts & interviews
from their channelJeffrey Dayno, MD, Highlights Harmony Biosciences' Commitment to Patients, Passion and Purpose
Paragon Biosciences
How Paragon is Leading the Bio-Revolution
Paragon Biosciences
CiRC Biosciences--Advancing Vision Restoration Cell Therapy
Paragon Biosciences
Jeff Aronin Discusses the Acceleration of Life Science Innovation at Paragon Biosciences
Paragon Biosciences
Images
Similar investors
Flagship Pioneering is a firm that creates and builds companies to pioneer breakthroughs in science and technology for people and the planet, active for over 25 years.
Future Positive Capital's portfolio page showcasing companies across health, climate, and deeptech sectors.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
AlleyCorp is a firm of technologists, investors, and entrepreneurs that both builds and invests in transformative companies.
Averin Capital is an investment firm focused on the intersection of technology and health, backing teams building companies in areas such as early disease detection, treatment delivery, personalized care, and medical breakthroughs.